IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc., (NasdaqGM: SPPI) today announced that Rajesh C. Shrotriya, MD, Chairman, Chief Executive Officer, and President, and other members of senior management, will host a conference call and webcast to provide an update on RIT Oncology LLC, FUSILEV™ and the Company's near-term strategy.
